Patents by Inventor Sandra COHEN

Sandra COHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Expansion of NK and DC cells in vivo mediating immune response
    Patent number: 12011460
    Abstract: It is provided a method of expanding dendritic (DC) cells and/or natural killer (NK) cells in vivo in a patient comprising the steps of producing a graft of stem and progenitor cells cultured with UM171 or analogues therefrom and expanded before being administered to the patient. The expansion or increase in dendritic (DC) cells and/or natural killer (NK) cells population in the patient results in an increase immune response reducing transplant related mortality (TRM), severe graft-versus-host disease (GVHD), relapse, and/or severe viral infections.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: June 18, 2024
    Assignee: UNIVERSITE DE MONTREAL
    Inventors: Guy Sauvageau, Sandra Cohen, Jean Roy, Silvy Lachance, Jean-Sébastien Delisle, Jalila Chagraoui
  • EXPANSION OF NK AND DC CELLS IN VIVO MEDIATING IMMUNE RESPONSE
    Publication number: 20210085714
    Abstract: It is provided a method of expanding dendritic (DC) cells and/or natural killer (NK) cells in vivo in a patient comprising the steps of producing a graft of stem and progenitor cells cultured with UM171 or analogues therefrom and expanded before being administered to the patient. The expansion or increase in dendritic (DC) cells and/or natural killer (NK) cells population in the patient results in an increase immune response reducing transplant related mortality (TRM), severe graft-versus-host disease (GVHD), relapse, and/or severe viral infections.
    Type: Application
    Filed: February 20, 2019
    Publication date: March 25, 2021
    Inventors: Guy SAUVAGEAU, Sandra COHEN, Jean ROY, Silvy LACHANCE, Jean-Sébastien DELISLE, Jalila CHAGRAOUI